Latest News | Glenmark Inks Licensing Pact with Jiangsu Alph

Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd on Thursday said its arm Glenmark Specialty S A (GSSA) has signed a license agreement with Jiangsu Alphamab Biopharmaceuticals Co and 3D Medicines (Beijing) Co Ltd for KN035 (Envafolimab), used in cancer treatment.
Latest News | Glenmark Inks Licensing Pact with Jiangsu Alphamab, 3D Medicines for Cancer Drug.

Related Keywords

New Delhi , Delhi , India , China , Bihar , Beijing , Russia , United States , Chinese , America , Jiangsu Alphamab , Asia Pacific , Bharat Ratna , Glenn Saldanha , Karpoori Thakur , Tracon Pharma , D Medicines Beijing Co Ltd , National Medical Products Administration Chinese , Glenmark Pharmaceuticals Ltd On , Jiangsu Alphamab Biopharmaceuticals Co , Drug Administration , Glenmark Pharmaceuticals , Glenmark Pharmaceuticals Ltd , Middle East , Latin America , Who Is Karpoori , Know All About Former Bihar , Pharmaceuticals Chairman , Managing Glenn Saldanha , National Medical Products Administration , Biliary Tract ,